These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 468965

  • 1. Dopamine inhibition of stimulated growth hormone secretion: evidence for dopaminergic modulation of insulin- and L-dopa-induced growth hormone secretion in man.
    Woolf PD, Lantigua R, Lee LA.
    J Clin Endocrinol Metab; 1979 Sep; 49(3):326-30. PubMed ID: 468965
    [No Abstract] [Full Text] [Related]

  • 2. [Stimulation of growth hormone secretion by the anterior pituitary gland using L-DOPA compared to growth hormone secretion following argine, insulin and sleep].
    Lucke C, Höffken B, Morgner KD.
    Verh Dtsch Ges Inn Med; 1974 Sep; 80():1328-30. PubMed ID: 4454413
    [No Abstract] [Full Text] [Related]

  • 3. Inhibition of L-dopa-induced growth hormone stimulation by pyridoxine and chlorpromazine.
    Mims RB, Scott CL, Modebe O, Bethune JE.
    J Clin Endocrinol Metab; 1975 Feb; 40(2):256-9. PubMed ID: 1117978
    [Abstract] [Full Text] [Related]

  • 4. Failure of papaverine to alter L-dopa-influenced GH and PRL secretion.
    Cooper DS, Jacobs LS.
    J Clin Endocrinol Metab; 1977 Mar; 44(3):585-7. PubMed ID: 838852
    [Abstract] [Full Text] [Related]

  • 5. Dopaminergic regulation of growth hormone (GH) secretion in normal man: correlation of L-dopa and dopamine levels with the GH response.
    Bansal S, Lee LA, Woolf PD.
    J Clin Endocrinol Metab; 1981 Aug; 53(2):301-6. PubMed ID: 7251816
    [No Abstract] [Full Text] [Related]

  • 6. In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas.
    Peillon F, Cesselin F, Bression D, Zygelman N, Brandi AM, Nousbaum A, Mauborgne A.
    J Clin Endocrinol Metab; 1979 Nov; 49(5):737-41. PubMed ID: 489713
    [Abstract] [Full Text] [Related]

  • 7. Adrenergic and dopaminergic modulation of growth hormone and prolactin secretion in normal and tumor bearing human pituitaries in monolayer culture.
    Tallo D, Malarkey WB.
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1278-84. PubMed ID: 7298804
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of pimozide on the prolactin and somatotropin responses to L-dopa, and on the somatotropin response to hypoglycemia (author's transl)].
    Hernández JM, Morales SE, López MA.
    Rev Invest Clin; 1977 Dec; 29(3):201-7. PubMed ID: 918416
    [No Abstract] [Full Text] [Related]

  • 9. Dissociation of growth hormone and prolactin response to levodopa during pyridoxine administration.
    Delitala G, Masala A.
    Biomedicine; 1977 Jul; 27(6):219-22. PubMed ID: 20170
    [Abstract] [Full Text] [Related]

  • 10. Effects of dexamethasone on growth hormone (GH)-releasing hormone, arginine- and dopaminergic stimulated GH secretion, and total plasma insulin-like growth factor-I concentrations in normal male volunteers.
    Miell JP, Corder R, Pralong FP, Gaillard RC.
    J Clin Endocrinol Metab; 1991 Mar; 72(3):675-81. PubMed ID: 1671785
    [Abstract] [Full Text] [Related]

  • 11. Loss of central nervous system component of dopaminergic inhibition of prolactin secretion in patients with prolactin-secreting pituitary tumors.
    Fine SA, Frohman LA.
    J Clin Invest; 1978 Apr; 61(4):973-80. PubMed ID: 659585
    [Abstract] [Full Text] [Related]

  • 12. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
    Ishibashi M, Yamaji T.
    J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
    [Abstract] [Full Text] [Related]

  • 13. Regulation of growth hormone and prolactin secretion in patients with acromegaly and-or excessive prolactin secretion.
    Cryer PE, Jacobs LS, Daughaday WH.
    Mt Sinai J Med; 1973 Jan; 40(3):402-13. PubMed ID: 4197309
    [No Abstract] [Full Text] [Related]

  • 14. Suppression by thyrotropin-releasing hormone (TRH) of growth hormone release induced by arginine and insulin-induced hypoglycemia in man.
    Maeda K, Kato Y, Chihara K, Ohgo S, Iwasaki Y.
    J Clin Endocrinol Metab; 1976 Aug; 43(2):453-6. PubMed ID: 820711
    [Abstract] [Full Text] [Related]

  • 15. [Influence of cimetidine on hypoglycemia-induced GH secretion].
    Campanella N, Morosini PP, Rinaldi L, Testa I, De Martinis C.
    Boll Soc Ital Biol Sper; 1979 Jan 15; 55(1):7-9. PubMed ID: 399438
    [Abstract] [Full Text] [Related]

  • 16. [Response of hGH to insulin hypoglycemia and to bromocriptine before and after the administration of L-dopa in primary hypothyroidism].
    Campino C, Pumarino H, Michelsen H, Piraino P, Generini G, Bruggendieck B.
    Rev Med Chil; 1985 Apr 15; 113(4):296-300. PubMed ID: 3915142
    [No Abstract] [Full Text] [Related]

  • 17. Blindness impairs plasma growth hormone response to L-dopa but not to arginine.
    Bellastella A, Parlato F, Sinisi AA.
    J Clin Endocrinol Metab; 1990 Apr 15; 70(4):856-8. PubMed ID: 2318945
    [Abstract] [Full Text] [Related]

  • 18. Prolactin and growth hormone responses in the amenorrhea-galactorrhea syndrome.
    Hagen TC, Sill AJ, Garthwaite TL, Halverson G, Borkowf HI.
    Obstet Gynecol; 1980 Aug 15; 56(2):204-7. PubMed ID: 7190256
    [Abstract] [Full Text] [Related]

  • 19. Differential effects of L-dopa and apomorphine on glucagon secretion in man: evidence against central dopaminergic stimulation of glucagon.
    Lorenzi M, Tsalikian E, Bohannon NV, Gerich JE, Karam JH, Forsham PH.
    J Clin Endocrinol Metab; 1977 Dec 15; 45(6):1154-8. PubMed ID: 591612
    [Abstract] [Full Text] [Related]

  • 20. Preservation of dopaminergic and alpha-adrenergic function in children with growth hormone neurosecretory dysfunction.
    Bercu BB, Root AW, Shulman DI.
    J Clin Endocrinol Metab; 1986 Oct 15; 63(4):968-73. PubMed ID: 3018032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.